Neuroprotective anti-apoptosis effect of estrogens in traumatic brain injury

Traumatic brain injury (TBI) is a leading cause of death and functional disability in western countries, affecting mostly young patients. Despite intense and sustained efforts deployed for the development of new therapeutic strategies, no clinical benefit has been shown by any of the investigated co...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of neurotrauma Vol. 22; no. 3; p. 345
Main Authors:	Soustiel, Jean F, Palzur, Eilam, Nevo, Ori, Thaler, Itzhak, Vlodavsky, Eugene
Format:	Journal Article
Language:	English
Published:	United States 01-03-2005
Subjects:	Animals Apoptosis - drug effects Apoptosis - physiology bcl-2-Associated X Protein Brain Injuries - drug therapy Brain Injuries - pathology Brain Injuries - prevention & control Caspase 3 Caspases - biosynthesis Estrogens - pharmacology Estrogens - therapeutic use Male Neuroprotective Agents - pharmacology Neuroprotective Agents - therapeutic use Proto-Oncogene Proteins c-bcl-2 - biosynthesis Rats Rats, Sprague-Dawley
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Traumatic brain injury (TBI) is a leading cause of death and functional disability in western countries, affecting mostly young patients. Despite intense and sustained efforts deployed for the development of new therapeutic strategies, no clinical benefit has been shown by any of the investigated compounds. Increasing attention has been drawn during the past two decades to the neuroprotective effects of estrogens, although most of the available data relate to ischemic brain injury. The purpose of the present study was to investigate the potential neuroprotective value of estrogens in TBI as a therapeutic modality. For this purpose, a contusion was created in the parietal cortex by dynamic cortical deformation in two groups of 10 Sprague-Dawley male rats. Following the injury, treated animals received conjugated estrogens for 3 days, using a subcutaneously implanted osmotic pump. Animals were then sacrificed, and TUNEL, anti-active Caspase 3, bcl-2, and bax labeling were performed in paraffin-embedded brain sections, allowing for comparative and quantitative analysis. In estrogen-treated animals, there was a marked and significant reduction of apoptosis in comparison with non-treated animals. The reduction in TUNEL and active Caspase 3 staining was similar and close to 50%. Optical analysis of histological slides prepared by bcl-2 labeling showed a significant increase in bcl-2 expression in estrogen-treated animals compared to non-treated animals. On the contrary, bax expression was not influenced by hormonal treatment, and no difference could be noticed between the two groups. These results support the potential therapeutic value of estrogens in TBI and further clarify their mode of action.
ISSN:	0897-7151
DOI:	10.1089/neu.2005.22.345